+Faculty OrientationUAMS BioVentures

April 21, 2023

Christopher A. FaselAssociate Director of LicensingPatent AttorneyUAMS BioVentures

+What is UAMS BioVentures?

+BioVentures’ 2 Primary Functions:

+Steps to Market:

+Invention to Commercialization: The Overview

2. InventionDisclosure

1. Research

5. Licensing4. Patent

Application

3. InventionAssessment

(Patent Committee)

6. Development

7. CommercializationPublic Funding

Private Funding

Inventors,Department, &

University

ResearchAgreement

Materials Transfer Agreement

ConfidentialityAgreement

Evaluation and OptionAgreement

Sales andService

Agreement

LicenseAgreement

Royalties $

Milestones $

Fees $

+Invention Disclosures at UAMS Invention Disclosure Form – Notifies UAMS that an invention has been made.

Begins the evaluation process.

Patent and Copyright Committee – Inventors discuss the invention with the Committee during a Friday afternoon meeting. The Committee evaluates the invention based upon protectability (e.g., patentability), marketability, value, and developmental stage.

Decision to File – If the Committee finds the invention protectable and valuable, UAMS will file a patent application or other protection, in the US or internationally. If the Committee does not feel the invention meets the threshold of patentability and marketability, or is the invention is not ready, the inventors will be given rights to continue development on their own.

Assignment – Inventors assign rights to the invention to the University of Arkansas, as required by Federal Statute governing inventions made using Federal research dollars.

Development & Marketing – The invention is licensed to a UAMS startup company or an outside company for further development, regulatory testing, production, and marketing.

Profits – Through royalties and fees, UAMS receives money from the marketing of the invention, and distributes the profits to the inventor, the inventor’s department, and the University.

+BioVentures Life Science Incubator

+Contact Us: